Interview with Tidepool’s CEO and Co-Founder Howard Look About an Automated Insulin Dosing App for Type 1 Diabetes

This episode features an interview with Howard Look, CEO and co-founder of Tidepool, a non-profit organization that has a range of software tools for people with diabetes and the clinics that serve them. 

Tidepool recently received US Food and Drug Administration (FDA) clearance of Tidepool Loop, an automated insulin dosing app meant for the management of type 1 diabetes in patients who are six years of age and older. Howard spoke about the FDA clearance and discussed how Tidepool Loop addresses an unmet need in the type 1 diabetes space.

Howard shared his story about his personal connection to diabetes and what prompted him to start Tidepool. He discussed his strategy for engaging stakeholders — the patients, health care providers, caregivers and payers — to pave the way for individuals with type 1 diabetes to access Tidepool Loop.

Hear more about Tidepool Loop and Tidepool’s continuing work in the diabetes management space.

Read more here:

Tidepool Loop Is FDA Cleared as an Automated Insulin Dosing App for Type 1 Diabetes

For more life science and medical device content, visit the Xtalks Vitals homepage.

Follow Us on Social Media

Twitter: @Xtalks
Instagram: @Xtalks
Facebook: https://www.facebook.com/Xtalks.Webinars/
LinkedIn: https://www.linkedin.com/company/xtalks-webconferences
YouTube: https://www.youtube.com/c/XtalksWebinars/featured